Technical Analysis for BJDX - Bluejay Diagnostics, Inc.

Grade Last Price % Change Price Change
F 0.08 -3.01% 0.00
BJDX closed down 3.01 percent on Friday, November 1, 2024, on 52 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.01%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bluejay Diagnostics, Inc. Description

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Cancer Clinical Medicine Infectious Diseases Inflammation Allergy Biomarkers Allergic Conjunctivitis Chemical Pathology Congestive Heart Failure Sepsis Conjunctivitis Lyme Disease Tick Borne Diseases

Is BJDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.28
52 Week Low 0.08
Average Volume 2,706,474
200-Day Moving Average 3.03
50-Day Moving Average 0.14
20-Day Moving Average 0.11
10-Day Moving Average 0.10
Average True Range 0.02
RSI (14) 27.54
ADX 18.82
+DI 16.86
-DI 27.70
Chandelier Exit (Long, 3 ATRs) 0.09
Chandelier Exit (Short, 3 ATRs) 0.13
Upper Bollinger Bands 0.13
Lower Bollinger Band 0.08
Percent B (%b) 0.01
BandWidth 42.12
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram 0.0031
Fundamentals Value
Market Cap 149.08 Thousand
Num Shares 1.78 Million
EPS -9.64
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 34.80
Price-to-Book 0.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.09
Resistance 3 (R3) 0.09 0.09 0.09
Resistance 2 (R2) 0.09 0.09 0.09 0.09
Resistance 1 (R1) 0.09 0.09 0.09 0.09 0.09
Pivot Point 0.08 0.08 0.08 0.08 0.08
Support 1 (S1) 0.08 0.08 0.08 0.08 0.08
Support 2 (S2) 0.08 0.08 0.08 0.08
Support 3 (S3) 0.07 0.08 0.08
Support 4 (S4) 0.07